"This new method will not only protect crops but also reduce our dependence on chemical pesticides," the Director of ZSI said ...

BEIJING -- Chinese scientists have developed a gene-editing technique to reduce corn plant height, enabling the creation of ...

A recent report has confirmed a concerning connection between harmful health effects in humans and fluorine exposure through ...

So maybe you've heard: the Super Bowl is this weekend! And you've probably also heard: President Trump will also be there! Oh ...

Equities researchers at Zacks Research lifted their Q4 2024 earnings estimates for Sarepta Therapeutics in a research note issued to investors on Monday, February 3rd. Zacks Research analyst S.

Ubrelvy and Nurtec are prescription medications taken to treat migraines. Though they share similarities, Ubrelvy is for acute treatment, while Nurtec can be taken for immediate symptom relief.

Researchers discovered the importance of an enzyme that promotes growth of certain lung cancers. Lung cancer is a ...

A new case report details a novel genetic mutation linked to drug resistance in a non-small cell lung cancer patient ...

We recently compiled a list of the Cathie Wood’s Stock Portfolio: 2025 Stock Picks. In this article, we are going to take a ...

Raymond James resumed coverage of Regenxbio (RGNX) with an Outperform rating and $27 price target The firm expects the launch of Elevidys and ...

As 2025 kicks off there’s lots of activity in the world of IP – particularly in the Biotech and Pharma sectors, writes Marc Wilkinson, Partner with J A Kemp. We at J A Kemp LLP have plenty to talk ...

A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled "Acquired RUFY1-RET rearrangement as a mechanism of resistance to lorlatinib in a patient with CD74-ROS1 ...